Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act, provisions related to Medicare and Medicaid; the Food and Drug Administration drug approval process; medical product supplies; health insurance coverage for COVID-19 testing and vaccinations; health care workforce support funding
H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, provisions relating to liability; PPE; pandemic planning and preparedness; telehealth; physician office testing; physician adverse economic impact and financial support; Medicare sequester exemption; CMS coverage for laboratory developed tests for COVID-19 virus; CMS accelerated payments; elective surgery suspension; funding for healthcare workforce support
S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act, provisions relating to liability; PPE; pandemic planning and preparedness; telehealth; physician office testing; physician adverse economic impact and financial support; Medicare sequester exemption; CMS coverage for laboratory developed tests for COVID-19 virus; CMS accelerated payments; elective surgery suspension; funding for healthcare workforce support
H.R. 6201, Families First Coronavirus Response Act, all provisions
H.R. 6379, Take Responsibility for Workers and Families Act, all provisions
FY2021 Appropriations, provisions relating to CDC/NIH funding for research on firearm morbidity and mortality prevention

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

H.R. 1763, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 5654, Expanding Medical Education Act of 2020, all provisions
H.R. 6090, Physician Shortage GME Cap Flex Act of 2020, all provisions

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions
H.R. 3630, No Surprises Act, all provisions
H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, all provisions
S. 1895, Lower Health Care Costs Act, all provisions
H.R. 5826, Consumer Protections Against Surprise Medical Bills Act of 2020, provisions relating to unanticipated billing for physician services, private contracting, rate setting
S. 1531, Stopping The Outrageous Practice of (STOP) Surprise Medical Bills Act of 2019, all provisions
H.R. 2279, Safe Step Act, all provisions
S. 2032, Cannabidiol and Marihuana Research Expansion Act, all provisions
H.R. 4004, Social Determinants Accelerator Act of 2019, all provisions
H.R. 6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, provisions relating to FDA oversight of laboratory developed tests
H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020, all provisions
H.R. 4742, Protecting American Lungs Act of 2019, all provisions
H.R. 5482, Providing Resources to End the Vaping Epidemic Now for Teenagers (PREVENT) Act of 2020, all provisions
H.R. 6139, COVID-19 Health Care Worker Protection Act of 2020, all provisions
S. 3559, A bill to provide emergency financial assistance to rural health care facilities and providers impacted by the COVID-19 emergency, all provisions
H.R. 4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019, all provisions
S. 2892, Opioid Workforce Act of 2019, all provisions
H.R. 2482, Mainstreaming Addiction Treatment Act of 2019, all provisions
H.R. 1503, Orange Book Transparency Act of 2019, all provisions
H.R. 1520, Purple Book Continuity Act of 2019, all provisions
H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, all provisions
H.R. 4995, Maternal Health Quality Improvement Act of 2019, all provisions

COVID-19 Pandemic
Affordable Care Act (ACA) stabilization
Immediate Relief for Rural Facilities and Providers Act of 2020, all provisions
Prescription drug pricing/transparency/importation/value/prior authorizations
Health reform/Universal coverage
Retired physicians
Public Health Emergency Fund financial assistance
Protecting physician speech
Opioids
Surprise billing
Health Disparities
Physician Suicide/Burnout
Telehealth
AMA Privacy Framework
Privacy legislation/administrative simplification
42 CFR Part 2, HIPAA
Augmented Intelligence (AI)/federal health IT strategy
Maternal mortality and morbidity
COVID-19 emergency declaration/Section 1135 authority
SARS-CoV-2 Testing
COVID-19/ personal protective equipment (PPE)
COVID-19/Controlled substances
Diabetes prevention
21st Century Cures Act
Pharmacy Benefits Manager (PBM)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Office of Management & Budget (OMB), Vice President of the U.S., White House Office, Office of Natl Drug Control Policy (NDCP), Federal Emergency Management Agency (FEMA), Drug Enforcement Administration (DEA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
J-1 Visas/duration of status
H-1B Visas
0-1 Visas
Confidential medical and psychological records of unaccompanied minors
Non-US citizen IMGs/COVID-19
Immigration

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), State - Dept of (DOS), Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), U.S. Immigration & Customs Enforcement (ICE)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

Health insurance industry consolidation/competition

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions relating to price transparency, value, and prior authorizations
H. R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions
H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
H.R. 6090, Physician Shortage GME Cap Flex Act of 2020, all provisions
S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 1301, Mental Health Telemedicine Expansion Act, all provisions
H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act of 2019, all provisions
H.R. 5201, Telemental Health Expansion Act of 2019, all provisions
H.R. 3414, Opioid Workforce Act of 2019, all provisions
H.R. 19, Lower Costs, More Cures Act of 2019, all provisions
H.R. 4996, Helping Medicaid Offer Maternity Services (MOMS) Act of 2019, all provisions
H.R. 4056, Medicare Audiologist Access and Services Act of 2019, all provisions

Medicare program: COVID-19 Pandemic
Medicare program: Regulatory Relief/Advanced Alternative Payment Models (APMs)/Stark modernization/prior authorization/utilization management
Medicare program: Physician-focused APMs
Medicare program: ASCOs Patient-Centered Oncology Payment model
Medicare program: Merit-based Incentive Payment System (MIPS)/cost, quality, promoting interoperability
Medicare program: 2020 Physician Fee schedule/Quality Payment Program/Inflation increase
Medicare program: Payment and delivery reform/misvalued codes/PTAC
Medicare program: Medicare for All
Medicare program: Interoperability and Data blocking
Medicare program: Privacy legislation/administrative simplification/COVID-19
Medicare program: Appropriate Use Criteria/advanced diagnostic imaging/COVID-19
Medicare program: Diabetes prevention
Medicare program: Health IT burden
Medicare program: Evaluation and Management (E&M)/2021 Budget neutrality
Medicare program: 2020 measure removal and testing policy
Medicare program: Pharmacy Benefits Manager (PBM)/Rx Drug Pricing Transparency
Medicare program: Open Payments
Medicare program: PECOS Enrollment/Revalidation
Medicare program: Scope of Practice
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)
implementation/physician payments/Accountable Care Organizations
Medicare and Medicaid programs: MACRA cost measure development
Medicare and Medicaid programs: Telehealth/remote psychologic monitoring/telephone E&M
Medicare and Medicaid programs: Opioids
Medicare and Medicaid programs: Defense Production Act (DPA)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

H.R. 4742, Protecting American Lungs Act of 2019, all provisions
H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020, all provisions
Tobacco
Vaping

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOR

16. Specific lobbying issues

H.R. 6283, Good Samaritan Health Professionals Act of 2020, inclusion in CARES Act
S. 1350, Good Samaritan Health Professionals Act of 2019, inclusion in CARES Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Scope of Practice
Veterans Choice/Community Care Program
Tricare Access

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes